48 results
DEFA14A
RPTX
Repare Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:07pm
Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to § 240.14a-12 … )
Payment of Filing Fee (Check all boxes that apply)
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit
8-K
EX-99.1
RPTX
Repare Therapeutics Inc
28 Feb 24
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:10am
to the satisfaction of the Company's performance obligations for the issuance of the combined licenses and the clinical trial materials transferred. The decrease
8-K
EX-99.1
oiraq0b
9 Nov 23
Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
7:05am
DEFA14A
yz4dz uvqwqw3qx
28 Apr 23
Additional proxy soliciting materials
4:07pm
8-K
8xiahfy
1 Jun 22
Entry into a Material Definitive Agreement
4:01pm
DEFA14A
z5r0x9 yuvic
1 Apr 22
Additional proxy soliciting materials
4:08pm